Explore the benefits of Nevro's HFX spinal cord stimulation device for diabetic peripheral neuropathy. Recent studies show up to two years of pain relief and enhanced...

Learn about hearing loss prevention and management during National Protect Your Hearing Month. Explore the link between diabetes and hearing loss, signs of impairment,...

In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.

Evelyn Oberdorfer, 65, is a bodybuilder and half-marathon runner. She credits building her resilience from managing the highs and lows of type 1 diabetes since childhood.

While some affirm the health benefits of caffeine, like improving insulin sensitivity and blood sugar, research is mixed on whether it's detrimental for people with...

Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.

People with diabetes who are U.S. citizens or permanent residents can apply for a free lifetime America the Beautiful Pass, which offers access to over 2,000 parks,...

Medtronic unveils Simplera, the latest CGM approved in Europe for people with diabetes ages two and older. A sleek, disposable device, Simplera rivals the Dexcom G7 and...

Ongoing hostilities and violence across the world leave people with diabetes in crisis and without access to essential resources. What can be done to help?

Explore the profound issue of diabetes stigma and steps we can take to combat it. From the Language Matters movement to personal stories and global pledges, discover how...

This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.

Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...

Rising type 2 diabetes rates demand new approaches. The 2022 ADA/EASD Consensus Report emphasizes person-centered care, medications for glycemic control and weight loss...

Hypo-RESOLVE collaborates internationally to advance hypoglycemia understanding in diabetes. Evolving from a once-understudied concern, its Hypo-METRICS app now captures...

Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...

Experts addressed rising rates of cardiovascular disease in children with diabetes at EASD 2023, emphasizing prevention and finding new biomarkers for early...

New research from the ReTUNE study of people with type 2 diabetes at a normal weight by Dr. Roy Taylor, University of Newcastle, found that type 2 diabetes is not caused...

At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...

Tirzepatide (sold as Mounjaro) is more effective than semaglutide (Ozempic) for both blood glucose control and weight loss, according to a new analysis.

Diabetic foot ulcers are a common and costly complication for people with diabetes. ON101 is a promising new topical treatment anticipated for FDA approval in the coming...